Global Life Science Business Partnering
Cross-border deals summary
Highlights of May 2020
- Indian companies – Cipla, Hetero and Jubilant has signed a licensing agreement with Gilead Sciences, Inc. for the manufacturing and distribution of ‘Remdesivir’ in 127 countries each, for COVID-19.
- ICMR teams up with Bharat Biotech to develop Covid-19 vaccine.
- Bharat Biotech and Thomas Jefferson partner on Covid-19 vaccine.
- Non-exclusive agreement signed between ICMR and Zydus-Cadila for Covid-19 antibody test kit.
- Novavax scores US$384 Million deal, CEPI's largest ever, to fund coronavirus vaccine work.
- GlaxoSmithKline hands Samsung Biologics US$231 Million to scale up manufacturing.
- Genocea inks license option deal on novel HSV-2 vaccine.
- Vännäs-based Agrisera has been acquired by Uppsala based biotech company Olink Proteomics.
- Puma Biotech and Bixink link up on Nerlynx marketing in South Korea.
- SERB expands presence in UK with acquisition of Veriton Pharma.
Highlights at Aagami
- BIO Digital 2020 – all time-slots filled. For an E–Meeting outside the BIO platform, please contact: Godwyn Francis – VP, Aagami, Inc. at Godwyn@aagami.com or call on +1 630 364 1837
- New Client Win: A French company developing a drug for smoking cessation from natural tobacco leaf extract. Only 2 injections needed for complete smoking cessation.
- New Client Win: Japanese company with on the market pro-immunity anti-cancer nutraceutical - Rapid and synchronized dormancy-broken Kyoho grape seed endosperm capsules. Currently sold in Japan and looking for marketing and selling partner for the US, India and across the world.
Some of the partnering opportunities available at Aagami are:
Available for Acquisition:
- PharmaPEG® technology - IP Portfolio & all associated data package to make Next-Generation Bio-Therapeutics.
- The related company is also open for acquisition.
Available for Licensing/Partnering/ Seeking Investor or Codeveloper:
- Seeking US$1.5M for Drug-device to delay the progression of Parkinson’s disease (PD), prevent Asian Flush and Hangover.
- Selection Technology using Bacteriocin-Immunity for Improved Microbial (E. coli.) Fermentation.
- Pro-immunity anti-cancer capsules of Rapid and synchronized dormancy-broken Kyoho grape seed endosperm from our Japanese client.
- Seeking US$1M for expansion of a Oncology focused healthcare and data science company.